CMV resistance in patients after allogeneic haematopoietic stem cell transplantation

被引:0
|
作者
Hubacek, P. [1 ,2 ]
Kouba, M. [3 ]
Boutolleau, D. [4 ]
Pliskova, L. [5 ]
Vejrazkova, E. [6 ]
Keslova, P. [7 ]
Sedlacek, P. [1 ,2 ]
Cetkovsky, P. [8 ]
机构
[1] Charles Univ Prague, Dept Paediat Haematol & Oncol, Prague, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
[3] Inst Hematol & Blood Transfus, Prague, Czech Republic
[4] Grp Hosp Pitie Salpetriere, Dept Virol, Paris, France
[5] Dept Clin Biochem & Diagnost, Hradec Kralove, Czech Republic
[6] Univ Hosp Hradec Kralove, Dept Haematol & Internal Med, Hradec Kralove, Czech Republic
[7] Motol Univ Hosp, Dept Paediat Haematol & Oncol, Prague, Czech Republic
[8] Inst Hematol & Blood Transfus, Dept Clin Haematol, Prague, Czech Republic
关键词
D O I
10.1016/j.jcv.2015.07.291
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
1790
引用
收藏
页码:S125 / S126
页数:2
相关论文
共 50 条
  • [1] CMV resistance in patients after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Kouba, M.
    Boutolleau, D.
    Pliskova, L.
    Vejrazkova, E.
    Keslova, P.
    Sedlacek, P.
    Cetkovsky, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S78 - S78
  • [2] CMV genotypes in patiens after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Javornicka, T.
    Sumova, J.
    Keslova, P.
    Kouba, M.
    Zajac, M.
    Markova-Stastna, M.
    Sedlacek, P.
    Cetkovsk, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S410 - S411
  • [3] Quantitative analysis of CMV DNA in children after allogeneic haematopoietic stem cell transplantation.
    Mellgren, Karin
    Kullberg-Lindh, Carola
    Lindh, Magnus
    Friman, Vanda
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 69 - 69
  • [4] Quality of life in patients after allogeneic haematopoietic stem cell transplantation
    Stancheva, N.
    Semenova, E.
    Zubarovskay, N.
    Paina, O.
    Vasilieva, Y.
    Alyansky, A.
    Bagge, D.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S88 - S88
  • [5] Lung transplantation after allogeneic haematopoietic stem cell transplantation
    Dodds, A.
    Potter, V.
    Bradstock, K.
    O'Brien, T.
    Glanville, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 216 - 216
  • [6] Mucormycosis after allogeneic haematopoietic stem cell transplantation
    Clement, L
    Salmon, A
    Mansuy, L
    Paczesny, S
    Bordigoni, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S205 - S205
  • [7] Haematopoietic reconstitution after autologous and allogeneic haematopoietic stem cell transplantation
    Pugachev, A.
    Mikhaylova, N.
    Golovacheva, A.
    Babenko, E.
    Estrina, M.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S306 - S306
  • [8] Risk factors of CMV reactivation post allogeneic haematopoietic stem cell transplantation
    Jaskula, E.
    Drabczak-Skrzypek, D.
    Mlynarczewska, A.
    Sedzimirska, M.
    Bogunia-Kubik, K.
    Lange, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S267 - S267
  • [9] High Dose Valaciclovir as CMV Prophylaxis in Allogeneic Haematopoietic Stem Cell Transplantation
    Douglas, Genevieve
    Yong, Michelle
    Tio, Shioyen
    Chau, Maggie
    Sasadeusz, Joe
    Slavin, Monica
    Ritchie, David
    Chee, Lynette
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 489 - 490
  • [10] Comparison of CMV antigenaemia and quantitative realtime PCR CMV-DNA assay in the detection of CMV infection in patients after allogeneic haematopoietic stem cell transplantation
    Gozdzik, J.
    Mordel, A.
    Lesko, E.
    Krasowska-Kwiecien, A.
    Kacinska, E.
    Wedrychowicz, A.
    Czogala, W.
    Wiecha, O.
    Skoczen, S.
    Majka, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S176 - S176